Programming biology: next-gen AI firms raise billions to design better medicines

Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03170-9

Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain.